I agree with what you say about MSA not being a widespread issue and not getting much publicity. If it was mentioned in a discussion, other than a ATH thread on HC, most people would think it was a chemical product that you buy at Bunnings...... or something like that.
Parkinson's, though, is well known to just about everyone and should feature in all presentations by management and announcements whever possible.
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial, page-119
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $301 | 86.51K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 60268641 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 126394327 | 25 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |